X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (33) 33
humans (32) 32
oncology (19) 19
dna methylation (17) 17
hematology (17) 17
cancer (15) 15
azacitidine - analogs & derivatives (14) 14
male (12) 12
leukemia, myeloid, acute - genetics (11) 11
aged (10) 10
female (10) 10
animals (9) 9
leukemia, myeloid, acute - drug therapy (9) 9
methylation (9) 9
middle aged (9) 9
acute myeloid-leukemia (8) 8
azacitidine - pharmacology (8) 8
epigenesis, genetic (8) 8
mice (8) 8
acute myeloid leukemia (7) 7
azacitidine - therapeutic use (7) 7
epigenetics (7) 7
hemic and lymphatic diseases (7) 7
leukemia (7) 7
promoter regions, genetic (7) 7
analysis (6) 6
cell line, tumor (6) 6
gene expression (6) 6
research (6) 6
transplantation (6) 6
adult (5) 5
aged, 80 and over (5) 5
antimetabolites, antineoplastic - therapeutic use (5) 5
antineoplastic agents - therapeutic use (5) 5
cells (5) 5
dna (5) 5
dna methylation - drug effects (5) 5
expression (5) 5
gene expression regulation, leukemic (5) 5
myelodysplastic syndromes - drug therapy (5) 5
neoplasms (5) 5
abridged index medicus (4) 4
aml (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
chemotherapy (4) 4
chromatin (4) 4
cpg islands (4) 4
decitabine (4) 4
deoxyribonucleic acid--dna (4) 4
gene (4) 4
genes, tumor suppressor (4) 4
hl-60 cells (4) 4
hypermethylation (4) 4
jurkat cells (4) 4
medicine (4) 4
myelodysplastic syndromes - genetics (4) 4
older patients (4) 4
oncology, experimental (4) 4
stem cells (4) 4
therapy (4) 4
treatment outcome (4) 4
valproic acid (4) 4
5-aza-2'-deoxycytidine (3) 3
acute disease (3) 3
antimetabolites, antineoplastic - pharmacology (3) 3
article (3) 3
azacitidine (3) 3
azacitidine - administration & dosage (3) 3
benzamides (3) 3
biochemistry & molecular biology (3) 3
c/ebp-alpha (3) 3
ccaat-enhancer-binding protein-alpha - genetics (3) 3
cell differentiation - genetics (3) 3
demethylation (3) 3
deoxyribonucleic acid (3) 3
differentiation (3) 3
dna binding proteins (3) 3
dna modification methylases - antagonists & inhibitors (3) 3
dna-methylation (3) 3
down-regulation (3) 3
gene-expression (3) 3
genes (3) 3
genetic aspects (3) 3
genetic research (3) 3
genomes (3) 3
hematology, oncology and palliative medicine (3) 3
histone deacetylase inhibitors (3) 3
imatinib mesylate (3) 3
leukemia, myeloid, acute - metabolism (3) 3
leukemia, myeloid, acute - pathology (3) 3
lung cancer (3) 3
medicine & public health (3) 3
multidisciplinary sciences (3) 3
myelodysplasia (3) 3
myelodysplastic syndrome (3) 3
research article (3) 3
science (3) 3
sequence analysis, dna (3) 3
u937 cells (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica, ISSN 0390-6078, 03/2012, Volume 97, Issue 3, pp. 393 - 401
Journal Article
Clinical Epigenetics, ISSN 1868-7075, 12/2010, Volume 1, Issue 3, pp. 117 - 136
Heritable changes in gene expression that are not based upon alterations in the DNA sequence are defined as epigenetics. The most common mechanisms of... 
Gene Function | Human Genetics | Biomedicine | ONCOLOGY
Journal Article
Im Focus Onkologie, ISSN 1435-7402, 11/2018, Volume 21, Issue 11, pp. 13 - 14
Journal Article
Cell, ISSN 0092-8674, 06/2007, Volume 129, Issue 5, pp. 879 - 890
Journal Article
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2014, Volume 9, Issue 6, pp. e100249 - e100249
Small Cell Lung Cancer (SCLC) is a specific subtype of lung cancer presenting as highly metastatic disease with extremely poor prognosis. Despite responding... 
ADHESION | STEM-CELLS | METASTASIS | MULTIDISCIPLINARY SCIENCES | CARCINOMAS | CHEMORESISTANCE | DIFFERENTIATION | IDENTIFICATION | ABERRANT EXPRESSION | CHEMOTHERAPY | CLINICAL-SIGNIFICANCE | Biomarkers - metabolism | Lung Neoplasms - genetics | Gene Expression | Cadherins - metabolism | Genetic Association Studies | Vimentin - metabolism | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Small Cell Lung Carcinoma - genetics | Epithelial-Mesenchymal Transition - genetics | Cell Movement - genetics | Small Cell Lung Carcinoma - metabolism | DNA Methylation | Drug Resistance, Neoplasm - genetics | Extracellular Space - metabolism | Small Cell Lung Carcinoma - pathology | Proteolysis | Vimentin - genetics | Cell Line, Tumor | Cadherins - genetics | Matrix Metalloproteinases - biosynthesis | Vimentin | Adherent cells | Biotechnology | Transcription factors | Thoracic surgery | Mesenchyme | Lung | Lung cancer | Oncology | Metastasis | Drug resistance | Kinases | Floating | Cancer therapies | E-cadherin | Fibronectin | Cell adhesion & migration | Metastases | Heterogeneity | Genotype & phenotype | DNA methylation | Deoxyribonucleic acid--DNA | Subpopulations | Hematology | Secretion | Tumor cells | Markers | Radiation therapy | Chemotherapy | Medical prognosis | Morphology | Cell lines | Stem cells | Information processing | Epigenetics | Methylation | Snail protein | Tumors | Cancer | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
by Mathew, Nimitha R and Baumgartner, Francis and Braun, Lukas and O'Sullivan, David and Thomas, Simone and Waterhouse, Miguel and Müller, Tony A and Hanke, Kathrin and Taromi, Sanaz and Apostolova, Petya and Illert, Anna L and Melchinger, Wolfgang and Duquesne, Sandra and Schmitt-Graeff, Annette and Osswald, Lena and Yan, Kai-Li and Weber, Arnim and Tugues, Sonia and Spath, Sabine and Pfeifer, Dietmar and Follo, Marie and Claus, Rainer and Lübbert, Michael and Rummelt, Christoph and Bertz, Hartmut and Wäsch, Ralph and Haag, Johanna and Schmidts, Andrea and Schultheiss, Michael and Bettinger, Dominik and Thimme, Robert and Ullrich, Evelyn and Tanriver, Yakup and Vuong, Giang Lam and Arnold, Renate and Hemmati, Philipp and Wolf, Dominik and Ditschkowski, Markus and Jilg, Cordula and Wilhelm, Konrad and Leiber, Christian and Gerull, Sabine and Halter, Jörg and Lengerke, Claudia and Pabst, Thomas and Schroeder, Thomas and Kobbe, Guido and Rösler, Wolf and Doostkam, Soroush and Meckel, Stephan and Stabla, Kathleen and Metzelder, Stephan K and Halbach, Sebastian and Brummer, Tilman and Hu, Zehan and Dengjel, Joern and Hackanson, Björn and Schmid, Christoph and Holtick, Udo and Scheid, Christof and Spyridonidis, Alexandros and Stölzel, Friedrich and Ordemann, Rainer and Müller, Lutz P and Sicre-De-Fontbrune, Flore and Ihorst, Gabriele and Kuball, Jürgen and Ehlert, Jan E and Feger, Daniel and Wagner, Eva-Maria and Cahn, Jean-Yves and Schnell, Jacqueline and Kuchenbauer, Florian and Bunjes, Donald and Chakraverty, Ronjon and Richardson, Simon and Gill, Saar and Kröger, Nicolaus and Ayuk, Francis and Vago, Luca and Ciceri, Fabio and Müller, Antonia M and Kondo, Takeshi and Teshima, Takanori and Klaeger, Susan and Kuster, Bernhard and Kim, Dennis H and Weisdorf, Daniel and Van Der Velden, Walter and Dörfel, Daniela and Bethge, Wolfgang and Hilgendorf, Inken and Hochhaus, Andreas and Andrieux, Geoffroy and Börries, Melanie and Busch, Hauke and Magenau, John and Reddy, Pavan and Labopin, Myriam and Antin, Joseph H and ...
Nature Medicine, ISSN 1078-8956, 03/2018, Volume 24, Issue 3, pp. 282 - 291
Individuals with acute myeloid leukemia (AML) harboring an internal tandem duplication (ITD) in the gene encoding Fms-related tyrosine kinase 3 (FLT3) who... 
ALLO-SCT | MEDICINE, RESEARCH & EXPERIMENTAL | INTERNAL TANDEM DUPLICATION | CONTROLLED-TRIAL | ACUTE GVHD | BIOCHEMISTRY & MOLECULAR BIOLOGY | REGULATORY FACTOR | ACUTE MYELOID-LEUKEMIA | TUMOR ACTIVITY | CELL BIOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | HOST-DISEASE | SEQUENCING DATA | Sorafenib - administration & dosage | Leukemia, Myeloid, Acute - pathology | Humans | Activating Transcription Factor 4 - genetics | Sorafenib - adverse effects | Interferon Regulatory Factor-7 - genetics | Graft vs Host Disease - pathology | fms-Like Tyrosine Kinase 3 - genetics | Graft vs Host Disease - genetics | Animals | Interleukin-15 - genetics | Graft vs Host Disease - drug therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Mice | Gene Expression Regulation, Neoplastic - drug effects | CD8-Positive T-Lymphocytes - immunology | Cellular Reprogramming - genetics | Tandem Repeat Sequences - genetics | Leukemia, Myeloid, Acute - genetics | Transplantation, Homologous - adverse effects | Interleukin-15 | Gene mutations | Gene expression | Health aspects | Chromatin | Animal models | Bcl-2 protein | PD-1 protein | CD8 antigen | Leukemia | Activation | Transplantation | Lymphocytes T | Synergism | Mitochondria | Cell activation | Lymphocytes | Rodents | Transcription activation | Flexible manufacturing systems | Protein-tyrosine kinase | Tyrosine | Cell survival | Myeloid leukemia | Activating transcription factor 4 | Interleukin 15 | Survival | Cells | Hemopoiesis | Interferon regulatory factor 7 | γ-Interferon | Glycolysis | Interferon | Acute myeloid leukemia | Interferon regulatory factor | Index Medicus
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 03/2006, Volume 98, Issue 6, pp. 396 - 406
Journal Article